James Hartley, “Aberrant Splicing Factor SF3A2 as a Prognostic Biomarker and Therapeutic Target in Colorectal Cancer: Interplay with Immune Infiltration and Natural Product Intervention”, ijmsdh, vol. 12, no. 09, pp. 176–181, Sep. 2026, doi: 10.55640/ijmsdh-12-09-20.